Ubs Asset Management Americas Inc Harmony Biosciences Holdings, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 61,653 shares of HRMY stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,653
Previous 68,372
9.83%
Holding current value
$2.09 Million
Previous $2.06 Million
19.45%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.1MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$380 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$198 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$118 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$88.2 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$65.3 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...